DAFTAR PUSTAKA

Abu-Alfa, Ali K., 2003, CKD series: Evaluation and treatment of anemia in chronic kidney
disease, Hospital Physician, 39.7, 31–38.
Alldredge, B.K., Corelli, R.L., dan Ernst, M.E., 2012, Koda-Kimble and Young’s Applied
Therapeutics: The Clinical Use of Drugs, Lippincott Williams & Wilkins.
Arnold, Reneé J.G., 2012, Pharmacoeconomics From Theory to Practice, CRC Press Taylor &
Francis Group, Boca Raton.
Carrol, L.E., 2006, The Stages of Chronic Kidney Disease and the Estimed Glomerular Filtratin
Rate, The Journal of Lancaster General Hospital, vol 1-2.
Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., & Posey, L.M., 2005,
Pharmacotherapy A Pathophysiologic Approach, 6th Ed, Mc Graw Hill, New York.
Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., & Posey, L.M., 2008,
Pharmacotherapy A Pathophysiologic Approach, 7th Ed, Mc Graw Hill, New York.
Jha, V., Wang, A.Y., dan Wang, H., 2012, The impact of CKD identification in large countries:
the burden of illness, Nephrology Dialysis Transplantation 27, Suppl 3, iii32–iii38.
KDIGO, 2012, Clinical Practice Guidelines for Anemia in Chronic Kidney Disease, Kidney
International Supplements, 2, 292–316, Boston, MA, USA.
KDOQI, 2002, Clinical Practice Guidelines For Chronic Kidney Disease: Evaluation,
Classification and Stratification, National Kidney Foundation, New York.
KDOQI, 2006, Clinical Practice Recommendations for Anemia in Chronic Kidney Disease,
National Kidney Foundation, New York.
Kementerian Kesehatan RI, 2013, Pokok Pokok Hasil Riskesdas Provinsi Daerah Istimewa
Yogyakarta 2013, Lembaga Penerbitan Badan Litbangkes, Jakarta.
Kumar, S., Baldi, A., 2013, Pharmacoeconomics: Principles, Methods and Economic Evaluation
of Drug Therapies, Pharmatech Media, 5, 362–369.
Lankhorst, C.E., Wish, J.B., 2010, Anemia in Renal Disease: Diagnosis and Management, Blood
Reviews., 24, 39–47.
Lozano, R., Naghavi M, Foreman K, et al., 2010, Global and regional mortality from 235 causes
of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden
of Disease Study 2010, Lancet, 380, 2095–2128.
Nissenson, A.R., Wade, S., Goodnough, T., et al, 2005, Economic Burden of Anemia in Insured
Population, Journal of Managed Care Pharmacy, 11, 565–574.
Nurko, S., 2006, Anemia in chronic kidney disease: Causes, diagnosis, treatment, Cleveland
Clinic Journal Of Medicine, 73(3), 289-297.
St. Peter, W.L., Khan, S.S., Ebben, J.P., et al, 2004, Chronic kidney disease: The distribution of
health care dollars, Kidney International, 66, 313–321.
Thomas, R., Kanso, A., Sedor, J.R., 2008, Chronic kidney disease and its complications, Prim
Care., 35, 329–344.
Turner, J.M., Bauer, C., Abramowitz, M.K., Melamed M.L., & Hostetter, T.H., 2012, Treatment
of chronic kidney disease, Kidney International, 81, 351–362.
UK Renal Registry, 2014, The 17th Annual Report, Renal Association, Bristol.
Walker, R., Edwards, C., 2012, Clinical Pharmacy and Therapeutics 5th ed, Churchill
Livingstone., Philadelphia.
WHO, 2008, Worldwide prevalence of anaemia 1993–2005 : WHO global database on anaemia,
WHO Press, Switzerland.